A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol.
- DOI
- 10.1186/s12885-024-13303-5
- Published
- 2024 Dec 21
- Container
- BMC cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-024-13303-5,
title = {A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol.},
author = {Courtney PT and L Santoso M and Savjani RR and K Reddy V and Chai-Ho W and Velez Velez MA and J Wong D and Palodichuk C and Basehart TV and P O'Connell D and Cao M and Telesca D and Chin RK},
year = {2024},
journal = {BMC cancer},
doi = {10.1186/s12885-024-13303-5},
url = {https://doi.org/10.1186/s12885-024-13303-5}
}RIS
TY - JOUR TI - A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol. AU - Courtney PT AU - L Santoso M AU - Savjani RR AU - K Reddy V AU - Chai-Ho W AU - Velez Velez MA AU - J Wong D AU - Palodichuk C AU - Basehart TV AU - P O'Connell D AU - Cao M AU - Telesca D AU - Chin RK PY - 2024 JO - BMC cancer DO - 10.1186/s12885-024-13303-5 UR - https://doi.org/10.1186/s12885-024-13303-5 ER -
APA
PT, C., M, L. S., RR, S., V, K. R., W, C., MA, V. V., D, J. W., C, P., TV, B., D, P. O., M, C., D, T., & RK, C. (2024). A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol.. BMC cancer. https://doi.org/10.1186/s12885-024-13303-5
Source records
- pubmed · retrieved 2026-09-27T07:05:13.070Z